Corinna Bang

Dr. Corinna Bang is a Research Fellow and Platform Leader for Microbiome Analysis at the Institute of Clinical Molecular Biology (IKMB), affiliated with Kiel University and the University Medical Center Schleswig-Holstein. Her research focuses on microbiome studies, particularly investigating the molecular interactions between microbial communities and human health, with emphasis on inflammatory and environmental diseases of the intestine.

Her work explores the complex crosstalk between microbial diversity and human physiology, examining how microbes evolve and influence chronic disease development. Key research interests include:

• Molecular analysis of gut microbiota using metagenomic approaches
• Archaea-immunology interactions
• Microbiome dynamics in inflammatory bowel diseases
• Environmental impacts on microbial ecology
• Therapeutic modulation of dysbiosis

Bang's recent publications (2019-2024) demonstrate strong focus on gut microbiome alterations in inflammatory conditions, therapeutic interventions, and host-microbe interactions. Her work frequently incorporates population-level studies, clinical trials, and molecular techniques to investigate microbiome diversity across diseases like IBD, multiple sclerosis, and hepatic disorders. Research consistently integrates genetic, immunological, and ecological perspectives.

She leads the Microbiome Lab at IKMB, overseeing high-throughput molecular analysis and biobanking for clinical and epidemiological studies. Her team collaborates extensively within the Genetics & Bioinformatics research group and participates in multi-institutional projects funded by organizations including the German Research Foundation (DFG).